Cargando…

Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy

PURPOSE: We investigated the drug use before and after transition to automated multi-dose dispensing (MDD) service among persons with Alzheimer’s disease (AD) and compared whether the changes were similar in persons without AD. METHODS: The register-based Finnish nationwide MEDALZ cohort includes 70...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallius, Sanna, Taipale, Heidi, Koponen, Marjaana, Tolppanen, Anna-Maija, Tanskanen, Antti, Hartikainen, Sirpa, Tiihonen, Miia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818643/ https://www.ncbi.nlm.nih.gov/pubmed/34837494 http://dx.doi.org/10.1007/s00228-021-03258-y

Ejemplares similares

Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)

Systemic Estrogen Use and Discontinuation After Alzheimer’s Disease Diagnosis in Finland 2005–2012: A Nationwide Exposure-Matched Cohort Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2018)

Antidementia drug use among community-dwelling individuals with Alzheimer’s disease in Finland: a nationwide register-based study
por: Taipale, Heidi, et al.
Publicado: (2014)

Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease
por: Ali Babar, Barkat, et al.
Publicado: (2022)

Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer’s disease research – the Medication use among persons with Alzheimer’s disease (MEDALZ-2005) study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2013)

Month and Season of Birth as a Risk Factor for Alzheimer’s Disease: A Nationwide Nested Case-control Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer’s Disease: A Cohort Study in Finland
por: Lavikainen, Piia, et al.
Publicado: (2020)

Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer’s Disease-Matched Cohort Study
por: Taipale, Heidi, et al.
Publicado: (2019)

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
por: Taipale, Heidi, et al.
Publicado: (2016)

Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer’s disease in 2005-2011
por: Tolppanen, Anna-Maija, et al.
Publicado: (2017)

Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease: a nationwide matched cohort study
por: Taipale, Heidi, et al.
Publicado: (2017)

Causes of death in a nationwide cohort of community-dwellers with Alzheimer’s disease
por: Tolppanen, Anna-Maija, et al.
Publicado: (2020)

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
por: Tanskanen, Antti, et al.
Publicado: (2015)

From prescriptions to drug use periods - things to notice
por: Tanskanen, Antti, et al.
Publicado: (2014)

Drug exposure in register-based research—An expert-opinion based evaluation of methods
por: Tanskanen, Antti, et al.
Publicado: (2017)

Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer’s Disease
por: Pisa, Federica, et al.
Publicado: (2021)

Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer’s Disease
por: Lintula, Eveliina, et al.
Publicado: (2019)

Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer’s disease – exposure-matched cohort study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016)

Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing—a cross-sectional study
por: Belfrage, Björn, et al.
Publicado: (2014)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer’s Disease
por: Tiihonen, Miia, et al.
Publicado: (2016)

Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
por: Bjerkeli, Pernilla J., et al.
Publicado: (2017)

Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents
por: Sodihardjo-Yuen, Fong, et al.
Publicado: (2016)

Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer’s Disease
por: Sarycheva, Tatyana, et al.
Publicado: (2018)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Coronary Revascularization and Postoperative Outcomes in People With and Without Alzheimer’s Disease
por: Vu, Mai, et al.
Publicado: (2021)

Changes in the use of diabetes drugs among community-dwelling people with Alzheimer’s disease
por: López-Rubio, Carlos, et al.
Publicado: (2021)

Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease
por: Sarycheva, Tatyana, et al.
Publicado: (2020)

Antiepileptic Drug Use and the Risk of Stroke Among Community‐Dwelling People With Alzheimer Disease: A Matched Cohort Study
por: Sarycheva, Tatyana, et al.
Publicado: (2018)

Incidence of antidepressant use among community dwellers with and without Parkinson’s disease – a nationwide cohort study
por: Hentilä, Eerik, et al.
Publicado: (2021)

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis
por: Paakinaho, Anne, et al.
Publicado: (2022)

Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes
por: Sunnarborg, Katriina, et al.
Publicado: (2022)

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
por: Paakinaho, Anne, et al.
Publicado: (2023)

Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany
por: Rausch, Christian, et al.
Publicado: (2020)

Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study
por: Gnjidic, Danijela, et al.
Publicado: (2014)

Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer’s disease: a matched cohort study
por: Rajamaki, Blair, et al.
Publicado: (2020)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_cti0hs5t23e9u76r3lelk1ks80